ID   DPEP1_HUMAN             Reviewed;         411 AA.
AC   P16444; D3DX80; Q96AK2;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   10-MAY-2017, entry version 185.
DE   RecName: Full=Dipeptidase 1;
DE            EC=3.4.13.19;
DE   AltName: Full=Dehydropeptidase-I;
DE   AltName: Full=Microsomal dipeptidase;
DE   AltName: Full=Renal dipeptidase;
DE            Short=hRDP;
DE   Flags: Precursor;
GN   Name=DPEP1; Synonyms=MDP, RDP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=8439558; DOI=10.1016/0167-4781(93)90289-P;
RA   Satoh S., Kusunoki C., Konta Y., Niwa M., Kohsaka M.;
RT   "Cloning and structural analysis of genomic DNA for human renal
RT   dipeptidase.";
RL   Biochim. Biophys. Acta 1172:181-183(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2303490;
RA   Adachi H., Tawaragi Y., Inuzuka C., Kubota I., Tsujimoto M.,
RA   Nishihara T., Nakazato H.;
RT   "Primary structure of human microsomal dipeptidase deduced from
RT   molecular cloning.";
RL   J. Biol. Chem. 265:3992-3995(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=7764673; DOI=10.1021/bp00026a002;
RA   Satoh S., Ohtsuka K., Keida Y., Kusunoki C., Konta Y., Niwa M.,
RA   Kohsaka M.;
RT   "Gene structural analysis and expression of human renal dipeptidase.";
RL   Biotechnol. Prog. 10:134-140(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 17-56; 111-121 AND 298-310.
RX   PubMed=2137335; DOI=10.1042/bj2650429;
RA   Hooper N.M., Keen J.N., Turner A.J.;
RT   "Characterization of the glycosyl-phosphatidylinositol-anchored human
RT   renal dipeptidase reveals that it is more extensively glycosylated
RT   than the pig enzyme.";
RL   Biochem. J. 265:429-433(1990).
RN   [8]
RP   PROTEIN SEQUENCE OF 17-39.
RX   PubMed=2768222;
RA   Adachi H., Kubota I., Okamura N., Iwata H., Tsujimoto M., Nakazato H.,
RA   Nishihara T., Noguchi T.;
RT   "Purification and characterization of human microsomal dipeptidase.";
RL   J. Biochem. 105:957-961(1989).
RN   [9]
RP   PROTEIN SEQUENCE OF 17-31.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally
RT   verified cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [10]
RP   GPI-ANCHOR AT SER-385.
RX   PubMed=2168407;
RA   Adachi H., Katayama T., Inuzuka C., Oikawa S., Tsujimoto M.,
RA   Nakazato H.;
RT   "Identification of membrane anchoring site of human renal dipeptidase
RT   and construction and expression of a cDNA for its secretory form.";
RL   J. Biol. Chem. 265:15341-15345(1990).
RN   [11]
RP   INHIBITION BY CHEMICAL MODIFICATION.
RX   PubMed=8097406; DOI=10.1016/0167-4838(93)90276-W;
RA   Adachi H., Katayama T., Nakazato H., Tsujimoto M.;
RT   "Importance of Glu-125 in the catalytic activity of human renal
RT   dipeptidase.";
RL   Biochim. Biophys. Acta 1163:42-48(1993).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-57 AND ASN-279.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 17-385 IN COMPLEX WITH ZINC
RP   AND CILASTATIN, SUBUNIT, COFACTOR, DISULFIDE BONDS, AND GLYCOSYLATION
RP   AT ASN-57 AND ASN-332.
RX   PubMed=12144777; DOI=10.1016/S0022-2836(02)00632-0;
RA   Nitanai Y., Satow Y., Adachi H., Tsujimoto M.;
RT   "Crystal structure of human renal dipeptidase involved in beta-lactam
RT   hydrolysis.";
RL   J. Mol. Biol. 321:177-184(2002).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-246.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Hydrolyzes a wide range of dipeptides. Implicated in the
CC       renal metabolism of glutathione and its conjugates. Converts
CC       leukotriene D4 to leukotriene E4; it may play an important role in
CC       the regulation of leukotriene activity.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of dipeptides.
CC       {ECO:0000255|PROSITE-ProRule:PRU10073}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10073,
CC         ECO:0000269|PubMed:12144777};
CC   -!- ENZYME REGULATION: Inhibited by L-penicillamine. {ECO:0000250}.
CC   -!- SUBUNIT: Homodimer; disulfide-linked. {ECO:0000255|PROSITE-
CC       ProRule:PRU10073, ECO:0000269|PubMed:12144777}.
CC   -!- INTERACTION:
CC       Q92624:APPBP2; NbExp=3; IntAct=EBI-749514, EBI-743771;
CC       Q96EK5:KIF1BP; NbExp=2; IntAct=EBI-749514, EBI-744150;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane; Lipid-anchor, GPI-
CC       anchor. Cell projection, microvillus membrane; Lipid-anchor, GPI-
CC       anchor. Note=Brush border membrane.
CC   -!- SIMILARITY: Belongs to the peptidase M19 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU10073}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D13137; BAA02430.1; -; Genomic_DNA.
DR   EMBL; J05257; AAB59410.1; -; mRNA.
DR   EMBL; D13138; BAA02431.1; -; mRNA.
DR   EMBL; S70330; AAC60630.2; -; Genomic_DNA.
DR   EMBL; S70329; AAC60630.2; JOINED; Genomic_DNA.
DR   EMBL; CH471184; EAW66719.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66720.1; -; Genomic_DNA.
DR   EMBL; BC017023; AAH17023.1; -; mRNA.
DR   EMBL; BT006664; AAP35310.1; -; mRNA.
DR   CCDS; CCDS10982.1; -.
DR   PIR; S29848; S29848.
DR   RefSeq; NP_001121613.1; NM_001128141.2.
DR   RefSeq; NP_004404.1; NM_004413.3.
DR   RefSeq; XP_005256342.1; XM_005256285.4.
DR   RefSeq; XP_005256343.1; XM_005256286.3.
DR   RefSeq; XP_011521227.1; XM_011522925.2.
DR   UniGene; Hs.109; -.
DR   PDB; 1ITQ; X-ray; 2.30 A; A/B=17-385.
DR   PDB; 1ITU; X-ray; 2.00 A; A/B=17-385.
DR   PDBsum; 1ITQ; -.
DR   PDBsum; 1ITU; -.
DR   ProteinModelPortal; P16444; -.
DR   SMR; P16444; -.
DR   BioGrid; 108134; 55.
DR   IntAct; P16444; 2.
DR   MINT; MINT-5000950; -.
DR   STRING; 9606.ENSP00000261615; -.
DR   BindingDB; P16444; -.
DR   ChEMBL; CHEMBL1989; -.
DR   DrugBank; DB01597; Cilastatin.
DR   DrugBank; DB06211; Doripenem.
DR   MEROPS; M19.001; -.
DR   iPTMnet; P16444; -.
DR   PhosphoSitePlus; P16444; -.
DR   BioMuta; DPEP1; -.
DR   DMDM; 92090943; -.
DR   EPD; P16444; -.
DR   MaxQB; P16444; -.
DR   PaxDb; P16444; -.
DR   PeptideAtlas; P16444; -.
DR   PRIDE; P16444; -.
DR   DNASU; 1800; -.
DR   Ensembl; ENST00000261615; ENSP00000261615; ENSG00000015413.
DR   Ensembl; ENST00000393092; ENSP00000376807; ENSG00000015413.
DR   Ensembl; ENST00000421184; ENSP00000397313; ENSG00000015413.
DR   GeneID; 1800; -.
DR   KEGG; hsa:1800; -.
DR   UCSC; uc002fnr.5; human.
DR   CTD; 1800; -.
DR   DisGeNET; 1800; -.
DR   GeneCards; DPEP1; -.
DR   HGNC; HGNC:3002; DPEP1.
DR   HPA; HPA009426; -.
DR   HPA; HPA012783; -.
DR   MIM; 179780; gene.
DR   neXtProt; NX_P16444; -.
DR   OpenTargets; ENSG00000015413; -.
DR   PharmGKB; PA144; -.
DR   eggNOG; KOG4127; Eukaryota.
DR   eggNOG; COG2355; LUCA.
DR   GeneTree; ENSGT00390000017920; -.
DR   HOGENOM; HOG000072016; -.
DR   HOVERGEN; HBG002339; -.
DR   InParanoid; P16444; -.
DR   KO; K01273; -.
DR   OMA; AFEDQLG; -.
DR   OrthoDB; EOG091G09CU; -.
DR   PhylomeDB; P16444; -.
DR   TreeFam; TF324523; -.
DR   BioCyc; MetaCyc:HS00367-MONOMER; -.
DR   BRENDA; 3.4.13.19; 2681.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-HSA-5423646; Aflatoxin activation and detoxification.
DR   SABIO-RK; P16444; -.
DR   EvolutionaryTrace; P16444; -.
DR   GeneWiki; Dipeptidase_1; -.
DR   GenomeRNAi; 1800; -.
DR   PRO; PR:P16444; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000015413; -.
DR   CleanEx; HS_DPEP1; -.
DR   ExpressionAtlas; P16444; baseline and differential.
DR   Genevisible; P16444; HS.
DR   GO; GO:0031225; C:anchored component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0045177; C:apical part of cell; IDA:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0031528; C:microvillus membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043027; F:cysteine-type endopeptidase inhibitor activity involved in apoptotic process; IMP:UniProtKB.
DR   GO; GO:0016805; F:dipeptidase activity; TAS:Reactome.
DR   GO; GO:0008239; F:dipeptidyl-peptidase activity; IEA:InterPro.
DR   GO; GO:0034235; F:GPI anchor binding; ISS:UniProtKB.
DR   GO; GO:0070573; F:metallodipeptidase activity; IDA:UniProtKB.
DR   GO; GO:0008235; F:metalloexopeptidase activity; TAS:UniProtKB.
DR   GO; GO:0072341; F:modified amino acid binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0016999; P:antibiotic metabolic process; IDA:UniProtKB.
DR   GO; GO:0072340; P:cellular lactam catabolic process; TAS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0035690; P:cellular response to drug; IDA:UniProtKB.
DR   GO; GO:0071732; P:cellular response to nitric oxide; ISS:UniProtKB.
DR   GO; GO:0006749; P:glutathione metabolic process; TAS:UniProtKB.
DR   GO; GO:0050667; P:homocysteine metabolic process; IDA:UniProtKB.
DR   GO; GO:0006691; P:leukotriene metabolic process; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:UniProtKB.
DR   GO; GO:0006805; P:xenobiotic metabolic process; TAS:Reactome.
DR   CDD; cd01301; rDP_like; 1.
DR   InterPro; IPR000180; Dipep_AS.
DR   InterPro; IPR028536; Dpep1.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   InterPro; IPR008257; Renal_dipep_fam.
DR   PANTHER; PTHR10443; PTHR10443; 1.
DR   PANTHER; PTHR10443:SF32; PTHR10443:SF32; 1.
DR   Pfam; PF01244; Peptidase_M19; 1.
DR   SUPFAM; SSF51556; SSF51556; 1.
DR   PROSITE; PS00869; RENAL_DIPEPTIDASE_1; 1.
DR   PROSITE; PS51365; RENAL_DIPEPTIDASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cell projection; Complete proteome;
KW   Dipeptidase; Direct protein sequencing; Disulfide bond; Glycoprotein;
KW   GPI-anchor; Hydrolase; Lipoprotein; Membrane; Metal-binding;
KW   Metalloprotease; Polymorphism; Protease; Reference proteome; Signal;
KW   Zinc.
FT   SIGNAL        1     16       {ECO:0000269|PubMed:15340161,
FT                                ECO:0000269|PubMed:2137335,
FT                                ECO:0000269|PubMed:2768222}.
FT   CHAIN        17    385       Dipeptidase 1.
FT                                /FTId=PRO_0000018652.
FT   PROPEP      386    411       Removed in mature form.
FT                                /FTId=PRO_0000018653.
FT   METAL        36     36       Zinc 1; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10073,
FT                                ECO:0000269|PubMed:12144777}.
FT   METAL        38     38       Zinc 1; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10073,
FT                                ECO:0000269|PubMed:12144777}.
FT   METAL       141    141       Zinc 1; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10073,
FT                                ECO:0000269|PubMed:12144777}.
FT   METAL       141    141       Zinc 2; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10073,
FT                                ECO:0000269|PubMed:12144777}.
FT   METAL       214    214       Zinc 2; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10073,
FT                                ECO:0000269|PubMed:12144777}.
FT   METAL       235    235       Zinc 2; catalytic. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10073,
FT                                ECO:0000269|PubMed:12144777}.
FT   BINDING     168    168       Substrate.
FT   BINDING     246    246       Substrate.
FT   BINDING     304    304       Substrate.
FT   LIPID       385    385       GPI-anchor amidated serine.
FT                                {ECO:0000269|PubMed:2168407}.
FT   CARBOHYD     57     57       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12144777,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    279    279       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    332    332       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:12144777}.
FT   CARBOHYD    358    358       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID     87    170       {ECO:0000255|PROSITE-ProRule:PRU10073,
FT                                ECO:0000269|PubMed:12144777}.
FT   DISULFID    242    274       {ECO:0000255|PROSITE-ProRule:PRU10073,
FT                                ECO:0000269|PubMed:12144777}.
FT   DISULFID    377    377       Interchain. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10073,
FT                                ECO:0000269|PubMed:12144777}.
FT   VARIANT     246    246       R -> H (in a colorectal cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_036496.
FT   VARIANT     351    351       E -> K (in dbSNP:rs1126464).
FT                                /FTId=VAR_061375.
FT   VARIANT     351    351       E -> Q (in dbSNP:rs1126464).
FT                                /FTId=VAR_061376.
FT   MUTAGEN     141    141       E->D,C: Complete loss of activity.
FT   MUTAGEN     141    141       E->Q: Partial loss of activity.
FT   CONFLICT      9      9       P -> S (in Ref. 1 and 3). {ECO:0000305}.
FT   CONFLICT    102    102       M -> R (in Ref. 2). {ECO:0000305}.
FT   CONFLICT    125    125       I -> R (in Ref. 2). {ECO:0000305}.
FT   HELIX        18     27       {ECO:0000244|PDB:1ITU}.
FT   STRAND       32     37       {ECO:0000244|PDB:1ITU}.
FT   HELIX        39     47       {ECO:0000244|PDB:1ITU}.
FT   HELIX        54     56       {ECO:0000244|PDB:1ITU}.
FT   TURN         58     60       {ECO:0000244|PDB:1ITU}.
FT   STRAND       63     65       {ECO:0000244|PDB:1ITU}.
FT   HELIX        68     73       {ECO:0000244|PDB:1ITU}.
FT   STRAND       76     83       {ECO:0000244|PDB:1ITU}.
FT   HELIX        87     89       {ECO:0000244|PDB:1ITU}.
FT   TURN         90     93       {ECO:0000244|PDB:1ITU}.
FT   HELIX        94    111       {ECO:0000244|PDB:1ITU}.
FT   TURN        113    115       {ECO:0000244|PDB:1ITU}.
FT   STRAND      116    118       {ECO:0000244|PDB:1ITU}.
FT   HELIX       122    131       {ECO:0000244|PDB:1ITU}.
FT   STRAND      134    141       {ECO:0000244|PDB:1ITU}.
FT   HELIX       143    146       {ECO:0000244|PDB:1ITU}.
FT   HELIX       150    158       {ECO:0000244|PDB:1ITU}.
FT   STRAND      161    166       {ECO:0000244|PDB:1ITU}.
FT   STRAND      168    170       {ECO:0000244|PDB:1ITU}.
FT   STRAND      173    175       {ECO:0000244|PDB:1ITU}.
FT   HELIX       178    180       {ECO:0000244|PDB:1ITU}.
FT   TURN        181    183       {ECO:0000244|PDB:1ITU}.
FT   STRAND      188    192       {ECO:0000244|PDB:1ITU}.
FT   HELIX       194    206       {ECO:0000244|PDB:1ITU}.
FT   STRAND      209    211       {ECO:0000244|PDB:1ITU}.
FT   HELIX       217    226       {ECO:0000244|PDB:1ITU}.
FT   STRAND      232    235       {ECO:0000244|PDB:1ITU}.
FT   TURN        239    241       {ECO:0000244|PDB:1ITU}.
FT   HELIX       250    259       {ECO:0000244|PDB:1ITU}.
FT   STRAND      262    265       {ECO:0000244|PDB:1ITU}.
FT   HELIX       269    272       {ECO:0000244|PDB:1ITU}.
FT   STRAND      274    276       {ECO:0000244|PDB:1ITU}.
FT   HELIX       280    294       {ECO:0000244|PDB:1ITU}.
FT   HELIX       296    298       {ECO:0000244|PDB:1ITU}.
FT   STRAND      299    301       {ECO:0000244|PDB:1ITU}.
FT   TURN        305    307       {ECO:0000244|PDB:1ITQ}.
FT   HELIX       321    330       {ECO:0000244|PDB:1ITU}.
FT   HELIX       335    342       {ECO:0000244|PDB:1ITU}.
FT   HELIX       344    356       {ECO:0000244|PDB:1ITU}.
FT   STRAND      359    361       {ECO:0000244|PDB:1ITU}.
FT   HELIX       370    372       {ECO:0000244|PDB:1ITU}.
FT   STRAND      375    377       {ECO:0000244|PDB:1ITU}.
FT   TURN        381    383       {ECO:0000244|PDB:1ITU}.
SQ   SEQUENCE   411 AA;  45674 MW;  C8C6474C3479D20D CRC64;
     MWSGWWLWPL VAVCTADFFR DEAERIMRDS PVIDGHNDLP WQLLDMFNNR LQDERANLTT
     LAGTHTNIPK LRAGFVGGQF WSVYTPCDTQ NKDAVRRTLE QMDVVHRMCR MYPETFLYVT
     SSAGIRQAFR EGKVASLIGV EGGHSIDSSL GVLRALYQLG MRYLTLTHSC NTPWADNWLV
     DTGDSEPQSQ GLSPFGQRVV KELNRLGVLI DLAHVSVATM KATLQLSRAP VIFSHSSAYS
     VCASRRNVPD DVLRLVKQTD SLVMVNFYNN YISCTNKANL SQVADHLDHI KEVAGARAVG
     FGGDFDGVPR VPEGLEDVSK YPDLIAELLR RNWTEAEVKG ALADNLLRVF EAVEQASNLT
     QAPEEEPIPL DQLGGSCRTH YGYSSGASSL HRHWGLLLAS LAPLVLCLSL L
//
